BMY
40
5
OI
36
-3
BWA
52
3
PM
70
21
MU
42
-2
AKAM
64
-2
UNP
49
3
CHD
54
-5
ILMN
57
-3
ZION
67
7
AEE
58
-2
NFLX
73
-3
APA
41
2
NUE
50
-8
JWN
55
-5
EL
40
-3
ROP
50
-3
TEL
63
-3
MLM
54
-7
WMT
62
3
BMY
40
5
OI
36
-3
BWA
52
3
PM
70
21
MU
42
-2
AKAM
64
-2
UNP
49
3
CHD
54
-5
ILMN
57
-3
ZION
67
7
AEE
58
-2
NFLX
73
-3
APA
41
2
NUE
50
-8
JWN
55
-5
EL
40
-3
ROP
50
-3
TEL
63
-3
MLM
54
-7
WMT
62
3
Financhill
Back

Akero Therapeutics Stock Predictions

Escape the market madness with 7 stocks to buy and hold

Get the complete list FREE for a limited time.
Buy
63

AKRO
Akero Therapeutics

Last Price:
29.62
Seasonality Move:
18.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Gold Set to Skyrocket as Fed Slashes Rates

Click here for the details on this incredible opportunity.

Akero Therapeutics Stock Forecast

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 29.9% based on the past 5 years of stock performance.
  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Akero Therapeutics Stock Undervalued?
    The current Akero Therapeutics [AKRO] share price is $29.59. The Score for AKRO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 29.9% based on the past 5 years of stock performance.

Akero Therapeutics Stock Rating

Buy
63
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics overpriced?

  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

  • The current trend is moderately bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com

52-Week Data

52-Week High:
37.00
52-Week Low:
11.25

Prediction Charts

Market Cap:
2.05B
Price in USD:
29.59
Volume:
339.43K
Beta:
-0.27

Technical Analysis

SMA50:
27.41
SMA100:
25.74
SMA200:
24.26
52-Wk Change:
137.1%

Stock Predictions

  • Is Akero Therapeutics stock public?
    Yes, Akero Therapeutics is a publicly traded company.
  • What is the Akero Therapeutics stock quote today?
    The Akero Therapeutics stock price is 29.59 USD today.
  • How to buy Akero Therapeutics stock online?
    You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-2 28.58 29.23 29.50 28.19
Oct-3 29.09 27.63 29.66 27.62
Oct-4 27.93 28.25 29.04 27.90
Oct-7 28.38 26.75 28.44 26.46
Oct-8 27.04 28.15 29.01 26.82
Oct-9 28.16 28.51 28.52 27.48
Oct-10 28.13 29.04 29.16 27.91
Oct-11 29.01 29.63 29.78 28.93
Oct-14 29.47 30.01 30.43 29.10
Oct-15 30.23 29.93 31.00 29.92
Oct-16 29.82 31.05 31.25 29.82
Oct-18 30.84 31.23 32.15 30.72
Oct-21 30.95 30.90 31.12 30.31
Oct-22 30.55 29.59 31.04 29.57

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.73 per share, and a decrease next year of $0.56 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.